General Information of This Antigen
Antigen ID
TAR0AABNG
Antigen Name
Sodium-dependent phosphate transport protein 2B (SLC34A2)
Gene Name
SLC34A2
Gene ID
10568
Synonym
Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2
Sequence
MAPWPELGDAQPNPDKYLEGAAGQQPTAPDKSKETNKTDNTEAPVTKIELLPSYSTATLI
DEPTEVDDPWNLPTLQDSGIKWSERDTKGKILCFFQGIGRLILLLGFLYFFVCSLDILSS
AFQLVGGKMAGQFFSNSSIMSNPLLGLVIGVLVTVLVQSSSTSTSIVVSMVSSSLLTVRA
AIPIIMGANIGTSITNTIVALMQVGDRSEFRRAFAGATVHDFFNWLSVLVLLPVEVATHY
LEIITQLIVESFHFKNGEDAPDLLKVITKPFTKLIVQLDKKVISQIAMNDEKAKNKSLVK
IWCKTFTNKTQINVTVPSTANCTSPSLCWTDGIQNWTMKNVTYKENIAKCQHIFVNFHLP
DLAVGTILLILSLLVLCGCLIMIVKILGSVLKGQVATVIKKTINTDFPFPFAWLTGYLAI
LVGAGMTFIVQSSSVFTSALTPLIGIGVITIERAYPLTLGSNIGTTTTAILAALASPGNA
LRSSLQIALCHFFFNISGILLWYPIPFTRLPIRMAKGLGNISAKYRWFAVFYLIIFFFLI
PLTVFGLSLAGWRVLVGVGVPVVFIIILVLCLRLLQSRCPRVLPKKLQNWNFLPLWMRSL
KPWDAVVSKFTGCFQMRCCCCCRVCCRACCLLCDCPKCCRCSKCCEDLEEAQEGQDVPVK
APETFDNITISREAQGEVPASDSKTECTAL

    Click to Show/Hide
Family
SEZ6 family
Function
Involved in actively transporting phosphate into cells via Na(+) cotransport.

    Click to Show/Hide
Uniprot Entry
NPT2B_HUMAN
HGNC ID
HGNC:11020
KEGG ID
hsa:10568
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
10H1.11.4B
ADC Info ADC Name Payload Target Linker Ref
CN109310885B ADC-4
CN109310885B ADC-4 payload
Undisclosed
CN109310885B ADC-4 linker
[1]
CN109310885B ADC-5
CN109310885B ADC-5 payload
Undisclosed
CN109310885B ADC-5 linker
[1]
CN109310885B ADC-6
CN109310885B ADC-6 payload
Undisclosed
CN109310885B ADC-6 linker
[1]
CN109310885B ADC-9
CN109310885B ADC-9 payload
Undisclosed
CN109310885B ADC-9 linker
[1]
CN109310885B ADC-10
CN109310885B ADC-10 payload
Undisclosed
CN109310885B ADC-10 linker
[1]
10H1.11.4B LC A149C
ADC Info ADC Name Payload Target Linker Ref
CN106714844B ADC-121
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
CN106714844B ADC-123
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
CN106714844B ADC-125
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
CN106714844B ADC-127
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
CN107206101B ADC-1
Dolastatin10
Undisclosed
MC-Sq-CIt-PAB
[3]
CN107206101B ADC-2-1
Tubulysin M
Undisclosed
MC-Sq-CIt-PAB
[3]
Anti- Napi2b Disulfide-Tubulysin M
Tubulysin M
Undisclosed
Disulfide linker
[3]
10H1.11B HC A118C
ADC Info ADC Name Payload Target Linker Ref
CN106714844B ADC-106
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
CN106714844B ADC-113
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[2]
Anti-NaPi-2b antibody
ADC Info ADC Name Payload Target Linker Ref
XMT-1592
AF-HPA
Microtubule (MT)
Cys-13 ADC linker
Anti-Napi2b Fc-silenced IgG1 mAb
ADC Info ADC Name Payload Target Linker Ref
TUB-040
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG24)-Val-Cit-PABC
Anti-NaPi2b mAb
ADC Info ADC Name Payload Target Linker Ref
YL205
YL0010014
DNA topoisomerase 1 (TOP1)
VK*G-NHCH2-O linker
Anti-NaPi2b mAb 10H1.11.4B
ADC Info ADC Name Payload Target Linker Ref
NaPi2b PNU ADC3-1
NaPi2b PNU ADC3-1 payload
Undisclosed
NaPi2b PNU ADC3-1 linker
[4]
NaPi2b PNU ADC4-1
NaPi2b PNU ADC4-1 payload
Undisclosed
NaPi2b PNU ADC4-1 linker
[4]
NaPi2b-PNU-LD1
NaPi2b-PNU-LD1 payload
Undisclosed
NaPi2b-PNU-LD1 linker
[4]
NaPi2b-PNU-LD2
NaPi2b-PNU-LD2 payload
Undisclosed
NaPi2b-PNU-LD2 linker
[4]
NaPi2b-PNU-LD5
NaPi2b-PNU-LD5 payload
Undisclosed
NaPi2b-PNU-LD5 linker
[4]
NaPi2b-PNU-LD6
NaPi2b-PNU-LD6 payload
Undisclosed
NaPi2b-PNU-LD6 linker
[4]
NaPi2b-PNU-LD7
NaPi2b-PNU-LD7 payload
Undisclosed
NaPi2b-PNU-LD7 linker
[4]
Anti-NaPi2b-LC-K149C
ADC Info ADC Name Payload Target Linker Ref
Alpha-NaPi2b-LC-K149C-10
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
[5]
Alpha-NaPi2b-LC-K149C-11
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
[5]
CN105828840B_ADC-134 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-134
CN105828840B_ADC-134 payload
Undisclosed
CN105828840B_ADC-134 linker
[6]
CN105828840B_ADC-135 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-135
CN105828840B_ADC-135 payload
Undisclosed
CN105828840B_ADC-135 linker
[6]
CN105828840B_ADC-136 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-136
CN105828840B_ADC-136 payload
Undisclosed
CN105828840B_ADC-136 linker
[6]
Fully humanized Anti-SLC34A2 IgG1 mAb
ADC Info ADC Name Payload Target Linker Ref
ZW-220
ZD06519
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly-AM
[7]
Lifastuzumab
ADC Info ADC Name Payload Target Linker Ref
Lifastuzumab vedotin
MMAE
Microtubule (MT)
Mc-Val-Cit-PABC
OT1:cHv83-1b15.G1 (L328C)k
ADC Info ADC Name Payload Target Linker Ref
AGL-01332-93 (BrAc) 2.43
CN114929286A 93
Undisclosed
AGL-01332 linker
[8]
AGL-01332-93CI 2.19
CN114929286A 93CI
Undisclosed
AGL-01332 linker
[8]
OT1:cHv83-3a23.G1 (L328C)k
ADC Info ADC Name Payload Target Linker Ref
AGL-01332-93 (BrAc) 1.98
CN114929286A 93
Undisclosed
AGL-01332 linker
[8]
AGL-01332-93CI 1.82
CN114929286A 93CI
Undisclosed
AGL-01332 linker
[8]
Thio Anti-Napi2B 10H1.11.4B LC V205C
ADC Info ADC Name Payload Target Linker Ref
WO2017214024A1 ADC-102
WO2017214024A1_ADC-102 payload
Undisclosed
WO2017214024A1_ADC-102 linker
[9]
Thio hu Anti-NaPi2b 10H1.11.4B LC K149C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-208
WO2017059289A1_ADC-208 payload
Undisclosed
WO2017059289A1_ADC-208 linker
[10]
Thio hu Anti-Napi3b 10H1.11.4B HC A118C
ADC Info ADC Name Payload Target Linker Ref
WO2014159981A2 ADC-205
WO2014159981A2_ADC-205 payload
Undisclosed
WO2014159981A2_ADC-205 linker
[11]
WO2014159981A2 ADC-SLC34A2-33
WO2014159981A2_ADC-SLC34A2-33 payload
Undisclosed
WO2014159981A2_ADC-SLC34A2-33 linker
[11]
WO2014159981A2 ADC-SLC34A2-37
WO2014159981A2_ADC-SLC34A2-37 payload
Undisclosed
WO2014159981A2_ADC-SLC34A2-37 linker
[11]
Upifitamab
ADC Info ADC Name Payload Target Linker Ref
Upifitamab rilsodotin
AF-HPA
Microtubule (MT)
Dolaflexin polymer
ADC Info ADC Name Payload Target Linker Ref
WO2018098269A2 conjugate 53A
WO2018098269A2_conjugate 53A payload
Undisclosed
WO2018098269A2_conjugate 53A linker
[12]
WO2018098269A2 conjugate 55A
WO2018098269A2_conjugate 55A payload
Undisclosed
WO2018098269A2_conjugate 55A linker
[12]
WO2018098269A2 conjugate 57
WO2018098269A2_conjugate 57 payload
Undisclosed
WO2018098269A2_conjugate 57 linker
[12]
WO2018098269A2 conjugate 59
WO2018098269A2_conjugate 59 payload
Undisclosed
WO2018098269A2_conjugate 59 linker
[12]
WO2018098269A2 conjugate 61
WO2018098269A2_conjugate 61 payload
Undisclosed
WO2018098269A2_conjugate 61 linker
[12]
WO2018098269A2 conjugate 66
WO2018098269A2_conjugate 66 payload
Undisclosed
WO2018098269A2_conjugate 66 linker
[12]
WO2018098269A2 conjugate 79A
WO2018098269A2_conjugate 79A payload
Undisclosed
WO2018098269A2_conjugate 79A linker
[12]
WO2018098269A2 conjugate 76
WO2018098269A2_conjugate 76 payload
Undisclosed
WO2018098269A2_conjugate 76 linker
[12]
WO2018098269A2 conjugate 83
WO2018098269A2_conjugate 83 payload
Undisclosed
WO2018098269A2_conjugate 83 linker
[12]
WO2018098269A2 conjugate 78
WO2018098269A2_conjugate 78 payload
Undisclosed
WO2018098269A2_conjugate 78 linker
[12]
WO2018098269A2 conjugate 85
WO2018098269A2_conjugate 85 payload
Undisclosed
WO2018098269A2_conjugate 85 linker
[12]
WO2018098269A2 conjugate 53B
WO2018098269A2_conjugate 53B payload
Undisclosed
WO2018098269A2_conjugate 53B linker
[12]
WO2018098269A2 conjugate 53C
WO2018098269A2_conjugate 53C payload
Undisclosed
WO2018098269A2_conjugate 53C linker
[12]
WO2018098269A2 conjugate 53D
WO2018098269A2_conjugate 53D payload
Undisclosed
WO2018098269A2_conjugate 53D linker
[12]
WO2018098269A2 conjugate 53E
WO2018098269A2_conjugate 53E payload
Undisclosed
WO2018098269A2_conjugate 53E linker
[12]
WO2018098269A2 conjugate 55B
WO2018098269A2_conjugate 55B payload
Undisclosed
WO2018098269A2_conjugate 55B linker
[12]
WO2018098269A2 conjugate 79B
WO2018098269A2_conjugate 79B payload
Undisclosed
WO2018098269A2_conjugate 79B linker
[12]
CN109310885B ADC-1
CN109310885B ADC-1 payload
Undisclosed
CN109310885B ADC-1 linker
[1]
CN109310885B ADC-2
CN109310885B ADC-2 payload
Undisclosed
CN109310885B ADC-2 linker
[1]
CN109310885B ADC-3
CN109310885B ADC-3 payload
Undisclosed
CN109310885B ADC-3 linker
[1]
AU2017363246B2 Conjugate53A
AU2017363246B2+Conjugate53+Payload
Undisclosed
AU2017363246B2+Conjugate53+Linker
[13]
AU2017363246B2 Conjugate53B
AU2017363246B2+Conjugate53+Payload
Undisclosed
AU2017363246B2+Conjugate53+Linker
[13]
AU2017363246B2 Conjugate53C
AU2017363246B2+Conjugate53+Payload
Undisclosed
AU2017363246B2+Conjugate53+Linker
[13]
AU2017363246B2 Conjugate53D
AU2017363246B2+Conjugate53+Payload
Undisclosed
AU2017363246B2+Conjugate53+Linker
[13]
AU2017363246B2 Conjugate53E
AU2017363246B2+Conjugate53+Payload
Undisclosed
AU2017363246B2+Conjugate53+Linker
[13]
AU2017363246B2 Conjugate55A
AU2017363246B2+Conjugate55+Payload
Undisclosed
AU2017363246B2+Conjugate55+Linker
[13]
AU2017363246B2 Conjugate55B
AU2017363246B2+Conjugate55+Payload
Undisclosed
AU2017363246B2+Conjugate55+Linker
[13]
AU2017363246B2 Conjugate55C
AU2017363246B2+Conjugate55+Payload
Undisclosed
AU2017363246B2+Conjugate55+Linker
[13]
AU2017363246B2 Conjugate57
AU2017363246B2+Conjugate57+Payload
Undisclosed
AU2017363246B2+Conjugate57+Linker
[13]
AU2017363246B2 Conjugate59
AU2017363246B2+Conjugate59+Payload
Undisclosed
AU2017363246B2+Conjugate59+Linker
[13]
AU2017363246B2 Conjugate61
AU2017363246B2+Conjugate61+Payload
Undisclosed
AU2017363246B2+Conjugate61+Linker
[13]
AU2017363246B2 Conjugate66
AU2017363246B2+Conjugate66+Payload
Undisclosed
AU2017363246B2+Conjugate66+Linker
[13]
AU2017363246B2 Conjugate76
AU2017363246B2+Conjugate76+Payload
Undisclosed
AU2017363246B2+Conjugate76+Linker
[13]
AU2017363246B2 Conjugate78
AU2017363246B2+Conjugate78+Payload
Undisclosed
AU2017363246B2+Conjugate78+Linker
[13]
AU2017363246B2 Conjugate79A
AU2017363246B2+Conjugate79+Payload
Undisclosed
AU2017363246B2+Conjugate79+Linker
[13]
AU2017363246B2 Conjugate79B
AU2017363246B2+Conjugate79+Payload
Undisclosed
AU2017363246B2+Conjugate79+Linker
[13]
AU2017363246B2 Conjugate83
AU2017363246B2+Conjugate83+Payload
Undisclosed
AU2017363246B2+Conjugate83+Linker
[13]
AU2017363246B2 Conjugate85
AU2017363246B2+Conjugate85+Payload
Undisclosed
AU2017363246B2+Conjugate85+Linker
[13]
WO2019126691A1 Conjugate No.20A
Conjugate No.10 Payload
Undisclosed
Conjugate No.5 Linker
[14]
WO2019126691A1 Conjugate No.73A
Conjugate No.67 Payload
Undisclosed
Conjugate No.73 Linker
[14]
WO2019126691A1 Conjugate No.94A
Conjugate No.94 Payload
Undisclosed
Conjugate No.94 Linker
[14]
WO2019126691A1 Conjugate No.135
Conjugate No.135 Payload
Undisclosed
Conjugate No.105 Linker
[14]
WO2019126691A1 Conjugate No.136
Conjugate No.136 Payload
Undisclosed
Conjugate No.105 Linker
[14]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
BSI-715
Undisclosed
Undisclosed
Undisclosed
[15]
Anti-NaPi3b antibody-drug conjugate (Genentech/Roche)
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
[16]
undisclosed
ADC Info ADC Name Payload Target Linker Ref
NaPi2b-STINGa
STINGa
Undisclosed
Undisclosed
[17]
ADRX-0134
AP052
Microtubule (MT)
Undisclosed
[18]
References
Ref 1 NaPi2b targeting antibody-drug conjugates and methods of use thereof.
Ref 2 Anthracycline disulfide intermediates, antibody-drug conjugates and methods
Ref 3 Quaternary ammonium compounds and their antibody-drug conjugates
Ref 4 Peptidomimetic compounds and antibody-drug conjugates thereof; 2015-09-03.
Ref 5 Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. Bioconjug Chem. 2019 May 15;30(5):1356-1370. doi: 10.1021/acs.bioconjchem.9b00133. Epub 2019 Apr 22.
Ref 6 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
Ref 7 ZW220, a novel NaPi2b-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload. Cancer Res (2023) 83 (7_Supplement): 1533.
Ref 8 Anti-SLC34A2 antibodies, antibody-drug conjugates and methods of use
Ref 9 Silvestrol antibody-drug conjugates and methods of use; 2017-12-14.
Ref 10 Pyrrolobenzodiazepine antibody drug conjugates and methods of use; 2017-04-06.
Ref 11 Pyrrolobenzodiazepines and conjugates thereof; 2015-04-09.
Ref 12 Peptide-containing linkers for antibody-drug conjugates.
Ref 13 Peptide-containing linkers for antibody-drug conjugates
Ref 14 Pyrrolobenzodiazepine antibody conjugates
Ref 15 Introduction to basic information on ADC drug BSI-715.
Ref 16 Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29(4):917-923.
Ref 17 Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Ref 18 ADRX-0134 as a novel auristatin-based NaPi2b antibody-drug conjugate with widened therapeutic window